GeneDx Holdings (WGS) Depreciation and Depletion (2025 - 2026)

GeneDx Holdings (WGS) posted quarterly Depreciation and Depletion of $2.7 million for Q1 2026, up 24.54% year-over-year from $2.2 million in Q1 2025, and up 24.54% quarter-over-quarter from $2.2 million in Q1 2025.

GeneDx Holdings (WGS) Depreciation and Depletion (2025 - 2026) Analysis & Trends

GeneDx Holdings (WGS) has reported Depreciation and Depletion for 2 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 331.00 Mn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 196.00 Mn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn 7.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 12.60 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 51.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 13.30 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn 108.00 Mn
10 GeneDx Holdings 2.08 Bn 1.94 Bn 78.24 Mn 3.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.10 Mn
Jun 30, 2026 3.10 Mn
Mar 31, 2026 2.71 Mn
Mar 31, 2026 2.71 Mn
Mar 31, 2025 2.17 Mn
Mar 31, 2025 2.17 Mn